End Stage Renal Disease (ESRD) Drug Global Market Report 2024

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $5,000	200 Pages	The Business Research Company	January, 2024	BRC18414601

Best Price Guarantee
Price	from $5,000
Length	200 Pages
Publisher	The Business Research Company
Published Date	January, 2024
SKU	BRC18414601

End Stage Renal Disease (ESRD) Drug Global Market Report 2024

Including: 1) By Product Type: Calcimimetics; Vitamin D; Sterols; Potassium Binders; Calcium-Based Phosphate Binders2) By Indication: End Stage Renal Disease (ESRD) Induced Hyperparathyroidism; End Stage Renal Disease (ESRD) Induced Hyperphosphatemia; End Stage Renal Disease (ESRD) Induced Hyperkaliemia3) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy4) By End User: Hospitals; Homecare; Specialty ClinicsCovering: Pfizer Inc.; AstraZeneca plc; Sanofi SA; Astellas Pharma Inc.; Novartis AG

End Stage Renal Disease (ESRD) Drug Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on end stage renal disease (esrd) drug market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Description:

Where is the largest and fastest growing market for end stage renal disease (esrd) drug? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The end stage renal disease (esrd) drug market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Scope

Markets Covered:1) By Product Type: Calcimimetics; Vitamin D; Sterols; Potassium Binders; Calcium-Based Phosphate Binders; Other Products

2) By Indication: End Stage Renal Disease (ESRD) Induced Hyperparathyroidism; End Stage Renal Disease (ESRD) Induced Hyperphosphatemia; End Stage Renal Disease (ESRD) Induced Hyperkaliemia

3) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy

4) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users

Companies Mentioned: Pfizer Inc.; AstraZeneca plc; Sanofi SA; Astellas Pharma Inc.; Novartis AG

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

1. Executive Summary
2. End Stage Renal Disease (ESRD) Drug Market Characteristics
3. End Stage Renal Disease (ESRD) Drug Market Trends And Strategies
4. End Stage Renal Disease (ESRD) Drug Market - Macro Economic Scenario: 4.1. Impact Of High Inflation On the Market; 4.2. Ukraine-Russia War Impact On the Market; 4.3. COVID-19 Impact On the Market
5. Global End Stage Renal Disease (ESRD) Drug Market Size and Growth: 5.1. Global End Stage Renal Disease (ESRD) Drug Market Drivers and Restraints; 5.1.1. Drivers Of The Market; 5.1.2. Restraints Of The Market; 5.2. Global End Stage Renal Disease (ESRD) Drug Historic Market Size and Growth, 2018 - 2023, Value ($ Billion); 5.3. Global End Stage Renal Disease (ESRD) Drug Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. End Stage Renal Disease (ESRD) Drug Market Segmentation: 6.1. Global End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; Calcimimetics; Vitamin D; Sterols; Potassium Binders; Calcium-Based Phosphate Binders; Other Products; 6.2. Global End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; End Stage Renal Disease (ESRD) Induced Hyperparathyroidism; End Stage Renal Disease (ESRD) Induced Hyperphosphatemia; End Stage Renal Disease (ESRD) Induced Hyperkalaemia; 6.3. Global End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; Hospital Pharmacy; Online Pharmacy; Retail Pharmacy; 6.4. Global End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; Hospitals; Homecare; Specialty Clinics; Other End Users
7. End Stage Renal Disease (ESRD) Drug Market Regional And Country Analysis: 7.1. Global End Stage Renal Disease (ESRD) Drug Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 7.2. Global End Stage Renal Disease (ESRD) Drug Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific End Stage Renal Disease (ESRD) Drug Market: 8.1. Asia-Pacific End Stage Renal Disease (ESRD) Drug Market Overview; Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies; 8.2. Asia-Pacific End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 8.3. Asia-Pacific End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 8.4. Asia-Pacific End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China End Stage Renal Disease (ESRD) Drug Market: 9.1. China End Stage Renal Disease (ESRD) Drug Market Overview; 9.2. China End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion; 9.3. China End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion; 9.4. China End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India End Stage Renal Disease (ESRD) Drug Market: 10.1. India End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 10.2. India End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 10.3. India End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan End Stage Renal Disease (ESRD) Drug Market: 11.1. Japan End Stage Renal Disease (ESRD) Drug Market Overview; 11.2. Japan End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 11.3. Japan End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 11.4. Japan End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia End Stage Renal Disease (ESRD) Drug Market: 12.1. Australia End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 12.2. Australia End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 12.3. Australia End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia End Stage Renal Disease (ESRD) Drug Market: 13.1. Indonesia End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 13.2. Indonesia End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 13.3. Indonesia End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea End Stage Renal Disease (ESRD) Drug Market: 14.1. South Korea End Stage Renal Disease (ESRD) Drug Market Overview; 14.2. South Korea End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 14.3. South Korea End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 14.4. South Korea End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe End Stage Renal Disease (ESRD) Drug Market: 15.1. Western Europe End Stage Renal Disease (ESRD) Drug Market Overview; 15.2. Western Europe End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 15.3. Western Europe End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 15.4. Western Europe End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK End Stage Renal Disease (ESRD) Drug Market: 16.1. UK End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 16.2. UK End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 16.3. UK End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany End Stage Renal Disease (ESRD) Drug Market: 17.1. Germany End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 17.2. Germany End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 17.3. Germany End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France End Stage Renal Disease (ESRD) Drug Market: 18.1. France End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 18.2. France End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 18.3. France End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy End Stage Renal Disease (ESRD) Drug Market: 19.1. Italy End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 19.2. Italy End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 19.3. Italy End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain End Stage Renal Disease (ESRD) Drug Market: 20.1. Spain End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 20.2. Spain End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 20.3. Spain End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe End Stage Renal Disease (ESRD) Drug Market: 21.1. Eastern Europe End Stage Renal Disease (ESRD) Drug Market Overview; 21.2. Eastern Europe End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 21.3. Eastern Europe End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 21.4. Eastern Europe End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia End Stage Renal Disease (ESRD) Drug Market: 22.1. Russia End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 22.2. Russia End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 22.3. Russia End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America End Stage Renal Disease (ESRD) Drug Market: 23.1. North America End Stage Renal Disease (ESRD) Drug Market Overview; 23.2. North America End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 23.3. North America End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 23.4. North America End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA End Stage Renal Disease (ESRD) Drug Market: 24.1. USA End Stage Renal Disease (ESRD) Drug Market Overview; 24.2. USA End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 24.3. USA End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 24.4. USA End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada End Stage Renal Disease (ESRD) Drug Market: 25.1. Canada End Stage Renal Disease (ESRD) Drug Market Overview; 25.2. Canada End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 25.3. Canada End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 25.4. Canada End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America End Stage Renal Disease (ESRD) Drug Market: 26.1. South America End Stage Renal Disease (ESRD) Drug Market Overview; 26.2. South America End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 26.3. South America End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 26.4. South America End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil End Stage Renal Disease (ESRD) Drug Market: 27.1. Brazil End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 27.2. Brazil End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 27.3. Brazil End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East End Stage Renal Disease (ESRD) Drug Market: 28.1. Middle East End Stage Renal Disease (ESRD) Drug Market Overview; 28.2. Middle East End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 28.3. Middle East End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 28.4. Middle East End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa End Stage Renal Disease (ESRD) Drug Market: 29.1. Africa End Stage Renal Disease (ESRD) Drug Market Overview; 29.2. Africa End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 29.3. Africa End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 29.4. Africa End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. End Stage Renal Disease (ESRD) Drug Market Competitive Landscape And Company Profiles: 30.1. End Stage Renal Disease (ESRD) Drug Market Competitive Landscape; 30.2. End Stage Renal Disease (ESRD) Drug Market Company Profiles; 30.2.1. Pfizer Inc.; 30.2.1.1. Overview; 30.2.1.2. Products and Services; 30.2.1.3. Strategy; 30.2.1.4. Financial Performance; 30.2.2. AstraZeneca plc; 30.2.2.1. Overview; 30.2.2.2. Products and Services; 30.2.2.3. Strategy; 30.2.2.4. Financial Performance; 30.2.3. Sanofi SA; 30.2.3.1. Overview; 30.2.3.2. Products and Services; 30.2.3.3. Strategy; 30.2.3.4. Financial Performance; 30.2.4. Astellas Pharma Inc.; 30.2.4.1. Overview; 30.2.4.2. Products and Services; 30.2.4.3. Strategy; 30.2.4.4. Financial Performance; 30.2.5. Novartis AG; 30.2.5.1. Overview; 30.2.5.2. Products and Services; 30.2.5.3. Strategy; 30.2.5.4. Financial Performance
31. Global End Stage Renal Disease (ESRD) Drug Market Competitive Benchmarking
32. Global End Stage Renal Disease (ESRD) Drug Market Competitive Dashboard
33. Key Mergers And Acquisitions In The End Stage Renal Disease (ESRD) Drug Market
34. End Stage Renal Disease (ESRD) Drug Market Future Outlook and Potential Analysis: 34.1 End Stage Renal Disease (ESRD) Drug Market In 2028 - Countries Offering Most New Opportunities; 34.2 End Stage Renal Disease (ESRD) Drug Market In 2028 - Segments Offering Most New Opportunities; 34.3 End Stage Renal Disease (ESRD) Drug Market In 2028 - Growth Strategies; 34.3.1 Market Trend Based Strategies; 34.3.2 Competitor Strategies
35. Appendix: 35.1. Abbreviations; 35.2. Currencies; 35.3. Historic And Forecast Inflation Rates; 35.4. Research Inquiries; 35.5. The Business Research Company; 35.6. Copyright And Disclaimer

PDF E-mail From Publisher:	$5,000
Site License Fulfilled by Publisher:	$7,500
Global Site License Fulfilled by Publisher:	$10,000

Show additional purchase options...

Research Assistance

US: 800.298.5699

Int'l: +1.240.747.3093

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

End Stage Renal Disease (ESRD) Drug Global Market Report 2024

Global End-Stage Renal Disease (ESRD) Drugs Market Growth 2024-2030

Global End-Stage Renal Disease (ESRD) Device Market Growth 2024-2030

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

End-Stage Renal Disease (ESRD) – Market Insight, Epidemiology, and Market Forecast – 2034

Global End Stage Renal Disease (ESRD) Treatment Market Growth (Status and Outlook) 2024-2030

Global End Stage Renal Disease (ESRD) Therapy Market Growth (Status and Outlook) 2024-2030

Research Assistance

Other tasks